Type of investor | Angel |
Typical investment size | $25,000 - $50,000 |
Typical investments in a year | 2 |
Locations of interest | |
Credentials | Accredited Investor |
Entrepreneur
I want to change the world.
Promaxo, Brex, Grail, Molekule
I had exited my last company and was working on my Executive MBA at Duke. I attended a NC Biotechnology event in Fall 2014, where Promaxo's one-of-its-kind, office-based MRI technology was being presented. I had a scintillating conversation with the inventor and after 15 months of due diligence and business planning, we were confident that we had an opportunity to make a positive impact in healthcare AND we made Promaxo happen!
The path of entrepreneurship and realizing innovation can be winding and lonely. I am fortunate to have the most supportive wife! However, working long days and spending countless hours away from loved ones can be frustrating. On the other hand, the most rewarding aspect of innovation is when it leads to a product that the customers can use. Specifically, in healthcare, positively impacting even a single patient's life is the ultimate reward.
Being too much in love with the original idea and not willing to adapt and/or listen to the voice of customers
- Believe in yourself and contantly strive to learn
- Be level-headed as the constant creasts and troughs of entrepreneurship can be exhilarating and stressful
- Have a clear vision and build a team with diverse and complementary skills and experiences
Dr. Amit Vohra is a serial entrepreneur, business strategist and advisor to several healthcare and technology startups. He is the Co-Founder of Promaxo and currently serves as the Company’s President & Chief Executive Officer. Amit is a Partner in Advanced Biopharma Consulting, a management consultancy offering strategic business development and commercialization services in the life sciences space. He is a Board Member at Navaux and Admac USA, and a West Coast Advisory Board Member for the Herbert Wertheim College of Engineering at the University of Florida. Prior to Promaxo, Amit was the President & CEO of Convergent Life Sciences wherein he took a product through FDA clearance within 18 months of Company formation. Previously, as VP of Strategy and Operations at Eigen, he led the development and successful commercialization of two class II medical devices in the prostate biopsy space. In 2009, Amit co-founded Navya Biomedical Technologies, a biotechnology company using proprietary polyhydroxy fullerenes for non-invasive imaging and destruction of solid tumors. Amit has a Doctorate in Mechanical Engineering from University of Florida, and an MBA (Fuqua Scholar) from Duke University’s Fuqua School of Business.